Login / Signup

Downregulation of ADAMTS3 Suppresses Stemness and Tumorigenicity in Glioma Stem Cell.

Hyun-Jin KimHang Yeon JeongDon Carlo BataraChangjong MoonSeongsoo LeeSuk Jun LeeSang-Ik ParkMoon-Chang ChoiSung-Hak Kim
Published in: CNS neuroscience & therapeutics (2022)
We identified ADAMTS3 as a potential therapeutic target for GBM.
Keyphrases
  • stem cells
  • signaling pathway
  • cell proliferation
  • epithelial mesenchymal transition
  • cell therapy
  • human health
  • risk assessment
  • bone marrow
  • cancer stem cells